Evidence-Based, Strategic Testing | Molecular Pathology Laboratory Network, Inc.

Evidence-Based, Strategic Testing

That's why MPLN offers StrataFLEX, a patient-specific reflex testing approach that strategically moves clinicians through the laboratory process, addresses each stage of patient management in a consultative, timely and cost-effective manner.

Strategic step-by-step testing addresses current, targeted therapies and maximizes information for the clinician. Through StrataFLEX, diagnosis is first achieved, while simultaneously focusing on prognostic and therapy-related information, setting the stage to monitor the patient over the course of treatment.

StrataFLEX Approach

Evidence-based testing that saves time and money
Streamlined ordering and reporting provides a complete diagnostic picture
Proactive clinical diagnostics, using personalized consultations and multidisciplinary concordance
One source for all complementary testing technologies

StrataFLEX makes a difference in patient care by coordinating laboratory tests and results within one facility using advanced, complementary technologies.

To determine the best testing strategy for each patient, our pathologists and laboratory directors consult with one another and the ordering physician to make the right move. This in-house multidisciplinary approach allows us to perform sequential testing on specimens to maximize information, while minimizing risk to sample integrity.

For more information about StrataFLEX, contact a technical client service specialist at 800.932.2943.